Just the Facts: Recce Pharmaceuticals scores 93% efficacy in Phase II trial

By Proactive Investors / February 17, 2025 / www.youtube.com / Article Link

Recce Pharmaceuticals Ltd has received positive Phase II clinical trial results for RECCE(R) 327 Topical Gel (R327G) in treating ...

Recent News

Gold stocks down as markets continue to new highs

July 21, 2025 / www.canadianminingreport.com

TSXV Top 20 Gold market cap shifts away from exploration

July 21, 2025 / www.canadianminingreport.com

Many new players enter TSXV gold Top 25 by market cap

July 14, 2025 / www.canadianminingreport.com

Gold stocks mixed on moderate metal gain, flat equities

July 14, 2025 / www.canadianminingreport.com

Gold stocks lead the large cap miners by far over H1/25

July 07, 2025 / www.canadianminingreport.com

See all >